Key facts
- Notable investors include CAS Star, Innoangel Fund, Zhongfalingchuang.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cytoship
- ·The full record, as it builds
Funding rounds
No funding rounds for Cytoship are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cytoship
Developer of innovative biotechnologies designed for targeted protein and nucleic acid delivery therapeutics. The company has developed a drug delivery technology platform that is expected to open up new directions in the field of drug delivery, enabling medical industry users with improvement of new quality productivity.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2024
- Employees
- 10
- Ownership
- Privately Held (backing)
Cytoship doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cytoship shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cytoship in its N-PORT filings yet. We sweep new filings monthly.